The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

vicarius-pharma.com

Total Raised

$21.8M

Investors Count

1

Deal Terms

1

Vicarius Pharma Funding, Vicarius Pharma Valuation & Vicarius Pharma Revenue

1 Fundings

Vicarius Pharma's latest funding round was a Series A for $21.8M on August 14, 2017.

Vicarius Pharma's latest post-money valuation is from August 2017.

Sign up for a free trial to see Vicarius Pharma's valuations in August 2017 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

8/14/2017

Series A

$21.8M

James Mullen, and Undisclosed Investors

$99M

0

FY undefined

5

Date

8/14/2017

Round

Series A

Amount

$21.8M

Investors

James Mullen, and Undisclosed Investors

Valuation

$99M

Revenue

0

FY undefined

Sources

5

Vicarius Pharma Deal Terms

1 Deal Term

Vicarius Pharma's deal structure is available for 1 funding round, including their Series A from August 14, 2017.

Round

Series A

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A

$99M

$99M

$99M

$99M

Vicarius Pharma Investors

1 Investors

Vicarius Pharma has 1 investors. James Mullen invested in Vicarius Pharma's Series A funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

8/14/2017

8/14/2017

1
Series A

Angel Investor (Individual)

First funding

8/14/2017

Last Funding

8/14/2017

Investor

Rounds

1
Series A

Board Seats

Type

Angel Investor (Individual)

Location

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.